A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients
Not Applicable
- Conditions
- Influenza virus infection
- Registration Number
- JPRN-UMIN000009479
- Lead Sponsor
- agasaki evaluation organization for clinical interventions
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)contraindication of peramivir and oseltamivir 2)pregnant or probable pregnant women 3)Inappropriate judged by doctors 4)pneumonia on the 1st day of visiting hospital
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The duration of fever
- Secondary Outcome Measures
Name Time Method Symptoms of influenza infection, viral titer and subtype, complications, exacerbation of underlying diseases, H275Y mutation of the virus isolated from the patients with poor clinical effects, The detection of colonized pneumococcus in nasal pharynx in the patients complicated secondary bacterial pneumonia